Casandra
Casandra Test Code PG91897Version 1 (DRAFT)
Performing Lab
Stroke, Cerebral Hemorrhage, Hemiplegia, and Migraine Panel
Clinical Use
Order TestUse
This test is intended for individuals with clinical or suspected diagnosis of stroke, cerebral hemorrhage, hemiplegia, or migraine, as well as those with a family history of these conditions. It aims to aid in the diagnosis by identifying genetic variants associated with these disorders.
Special Instructions
Not provided.
Limitations
The performance of this panel is validated under CAP and CLIA regulations. However, it has not been cleared or approved by the FDA, which may affect its availability or acceptance in certain jurisdictions. The presence of a familial or personal history of the diseases under study enhances the test’s utility for diagnostic purposes.
Test Details
New York Approved
Methodology
NGS (CGP)
Biomarkers
NGS with CNV Analysis • CGP
Result Turnaround Time
14-21 days
Related Documents
For more information, please review the documents below
Specimen Requirements
Specimen
Whole Blood
Volume
Not provided
Minimum Volume
Not provided